Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Optic pathway gliomas in adolescence--time to challenge treatment choices?

Chong AL, Pole JD, Scheinemann K, Hukin J, Tabori U, Huang A, Bouffet E, Bartels U.

Neuro Oncol. 2013 Mar;15(3):391-400. doi: 10.1093/neuonc/nos312. Epub 2013 Jan 7.

2.

Optic pathway hypothalamic gliomas in children under three years of age: the role of chemotherapy.

Silva MM, Goldman S, Keating G, Marymont MA, Kalapurakal J, Tomita T.

Pediatr Neurosurg. 2000 Sep;33(3):151-8.

PMID:
11096362
3.

The role of surgery in optic pathway/hypothalamic gliomas in children.

Goodden J, Pizer B, Pettorini B, Williams D, Blair J, Didi M, Thorp N, Mallucci C.

J Neurosurg Pediatr. 2014 Jan;13(1):1-12. doi: 10.3171/2013.8.PEDS12546. Epub 2013 Oct 18.

PMID:
24138145
5.

Radiation therapy of optico-hypothalamic gliomas (OHG)--radiographic response, vision and late toxicity.

Grabenbauer GG, Schuchardt U, Buchfelder M, Rödel CM, Gusek G, Marx M, Doerr HG, Fahlbusch R, Huk WJ, Wenzel D, Sauer R.

Radiother Oncol. 2000 Mar;54(3):239-45.

PMID:
10738082
6.

Optic glioma in children: a retrospective analysis of 101 cases.

Varan A, Batu A, Cila A, Soylemezoğlu F, Balcı S, Akalan N, Zorlu F, Akyüz C, Kutluk T, Büyükpamukçu M.

Am J Clin Oncol. 2013 Jun;36(3):287-92. doi: 10.1097/COC.0b013e3182467efa.

PMID:
22547006
7.

Optic pathway and hypothalamic/chiasmatic gliomas in children younger than age 5 years with a 6-year follow-up.

Janss AJ, Grundy R, Cnaan A, Savino PJ, Packer RJ, Zackai EH, Goldwein JW, Sutton LN, Radcliffe J, Molloy PT, et al.

Cancer. 1995 Feb 15;75(4):1051-9.

8.

Outcomes of multidisciplinary management in pediatric low-grade gliomas.

Oh KS, Hung J, Robertson PL, Garton HJ, Muraszko KM, Sandler HM, Hamstra DA.

Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):e481-8. doi: 10.1016/j.ijrobp.2011.01.019. Epub 2011 Apr 4.

PMID:
21470783
9.

Natural history and outcome of optic pathway gliomas in children.

Nicolin G, Parkin P, Mabbott D, Hargrave D, Bartels U, Tabori U, Rutka J, Buncic JR, Bouffet E.

Pediatr Blood Cancer. 2009 Dec 15;53(7):1231-7. doi: 10.1002/pbc.22198.

PMID:
19621457
10.

Visual acuity of children treated with chemotherapy for optic pathway gliomas.

Kalin-Hajdu E, Décarie JC, Marzouki M, Carret AS, Ospina LH.

Pediatr Blood Cancer. 2014 Feb;61(2):223-7. doi: 10.1002/pbc.24726. Epub 2013 Aug 19.

PMID:
23956233
11.

Management of optic pathway and chiasmatic-hypothalamic gliomas in children with radiation therapy.

Erkal HS, Serin M, Cakmak A.

Radiother Oncol. 1997 Oct;45(1):11-5.

PMID:
9364626
12.

Combined intraarterial carboplatin, intraarterial etoposide phosphate, and IV Cytoxan chemotherapy for progressive optic-hypothalamic gliomas in young children.

Osztie E, Várallyay P, Doolittle ND, Lacy C, Jones G, Nickolson HS, Neuwelt EA.

AJNR Am J Neuroradiol. 2001 May;22(5):818-23.

13.

Optic pathway glioma: outcome and prognostic factors in a surgical series.

Ahn Y, Cho BK, Kim SK, Chung YN, Lee CS, Kim IH, Yang SW, Kim HS, Kim HJ, Jung HW, Wang KC.

Childs Nerv Syst. 2006 Sep;22(9):1136-42. Epub 2006 Apr 21.

PMID:
16628460
14.

Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis.

Fisher MJ, Loguidice M, Gutmann DH, Listernick R, Ferner RE, Ullrich NJ, Packer RJ, Tabori U, Hoffman RO, Ardern-Holmes SL, Hummel TR, Hargrave DR, Bouffet E, Charrow J, Bilaniuk LT, Balcer LJ, Liu GT.

Neuro Oncol. 2012 Jun;14(6):790-7. doi: 10.1093/neuonc/nos076. Epub 2012 Apr 3.

15.

Treatment of optic pathway hypothalamic gliomas in childhood: experience with 18 consecutive cases.

Jaing TH, Lin KL, Tsay PK, Hsueh C, Hung PC, Wu CT, Tseng CK.

J Pediatr Hematol Oncol. 2008 Mar;30(3):222-4. doi: 10.1097/MPH.0b013e318162bd6a.

PMID:
18376285
16.

Long-term follow-up of the multicenter, multidisciplinary treatment study HIT-LGG-1996 for low-grade glioma in children and adolescents of the German Speaking Society of Pediatric Oncology and Hematology.

Gnekow AK, Falkenstein F, von Hornstein S, Zwiener I, Berkefeld S, Bison B, Warmuth-Metz M, Driever PH, Soerensen N, Kortmann RD, Pietsch T, Faldum A.

Neuro Oncol. 2012 Oct;14(10):1265-84. Epub 2012 Aug 31.

17.

Long-term outcome in children with gliomas of the anterior visual pathway.

Tow SL, Chandela S, Miller NR, Avellino AM.

Pediatr Neurol. 2003 Apr;28(4):262-70.

PMID:
12849878
18.

Tumor stabilization under treatment with imatinib in progressive hypothalamic-chiasmatic glioma.

Peyrl A, Azizi A, Czech T, Gruber-Olipitz M, Jones N, Haberler C, Prayer D, Autzinger E, Slavc I.

Pediatr Blood Cancer. 2009 Apr;52(4):476-80. doi: 10.1002/pbc.21881.

PMID:
19061223
19.

Visual outcome following chemotherapy for progressive optic pathway gliomas.

Shofty B, Ben-Sira L, Freedman S, Yalon M, Dvir R, Weintraub M, Toledano H, Constantini S, Kesler A.

Pediatr Blood Cancer. 2011 Sep;57(3):481-5. doi: 10.1002/pbc.22967. Epub 2011 Jan 16.

PMID:
21241008
20.

Progression-free survival in children with optic pathway tumors: dependence on age and the quality of the response to chemotherapy--results of the first French prospective study for the French Society of Pediatric Oncology.

Laithier V, Grill J, Le Deley MC, Ruchoux MM, Couanet D, Doz F, Pichon F, Rubie H, Frappaz D, Vannier JP, Babin-Boilletot A, Sariban E, Chastagner P, Zerah M, Raquin MA, Hartmann O, Kalifa C; French Society of Pediatric Oncology.

J Clin Oncol. 2003 Dec 15;21(24):4572-8.

PMID:
14673044

Supplemental Content

Support Center